Predicted protein targets (top 12)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.38 |
| ▸ | ALOX15 | P16050 | 1/20 | 0.38 |
| ▸ | NFE2L2 | Q16236 | 1/20 | 0.37 |
| ▸ | CYP2D6 | P10635 | 2/20 | 0.35 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.35 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.35 |
| ▸ | TRPV1 | Q8NER1 | 3/20 | 0.34 |
| ▸ | TRPA1 | O75762 | 1/20 | 0.34 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.33 |
| ▸ | PPARG | P37231 | 1/20 | 0.33 |
| ▸ | FNTA | P49354 | 1/20 | 0.32 |
| ▸ | FNTB | P49356 | 1/20 | 0.32 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL11044385 | 0.86 | ALDH1A1 (0.38) | ALDH1A1ALOX15NFE2L2CYP2D6CYP3A4 | |
| SCHEMBL11042524 | 0.85 | FNTA (0.39) | ALDH1A1ALOX15NFE2L2CYP2D6CYP3A4 | |
| SCHEMBL11043412 | 0.85 | FNTA (0.39) | ALDH1A1ALOX15NFE2L2CYP2D6CYP3A4 | |
| SCHEMBL11045633 | 0.85 | FNTA (0.39) | ALDH1A1ALOX15NFE2L2CYP2D6CYP3A4 | |
| SCHEMBL11041963 | 0.85 | FNTA (0.39) | ALDH1A1ALOX15NFE2L2CYP2D6CYP3A4 | |
| SCHEMBL7686021 | 0.84 | NFE2L2 (0.43) | ALDH1A1ALOX15NFE2L2CYP2D6CYP3A4 | |
| SCHEMBL7686022 | 0.84 | NFE2L2 (0.43) | ALDH1A1ALOX15NFE2L2CYP2D6CYP3A4 | |
| SCHEMBL10000055 | 0.83 | NFE2L2 (0.44) | ALDH1A1ALOX15NFE2L2CYP2D6CYP3A4 | |
| SCHEMBL11043985 | 0.81 | KMT2A (0.45) | ALDH1A1ALOX15NFE2L2CYP2D6CYP3A4 | |
| SCHEMBL10565035 | 0.81 | KMT2A (0.45) | ALDH1A1ALOX15NFE2L2CYP2D6CYP3A4 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-5348974-A | Tocotrienols in the treatment of hypercholesterolemia, hyperlipidemia and thromboembolic disorders | BRISTOL-MYERS SQUIBB COMPANY (US) | 1994-09-20 | — | — | US | disclosed |
| US-5217992-A | Administering mixtures of tocotrienols to reduce serum cholesterol levels | BRISTOL-MYERS SQUIBB COMPANY (US) | 1993-06-08 | — | — | US | disclosed |
| EP-0421419-A2 | Tocotrienols in the treatment of hypercholesterolemia, hyperlipidemia and thromboembolic disorders | Bristol-Myers Squibb Company (US) | 1991-04-10 | — | — | EP | disclosed |